Stargazer Pharmaceuticals Investors

17 investors on Angel Roster list Stargazer Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, Israel and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Stargazer Pharmaceuticals can appear together.

Investors listed
17
With verified email
53%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 Stargazer Pharmaceuticals investors

The most complete profiles first. Showing 17 of 17.

  • Eric YoungVerified

    Venture Capital, Founder, Investor · United Kingdom

    SeedSeries BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Filanet, Hallo and 85 more

    Verified email available

  • Guy RussoVerified

    Venture Capital, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Jared NewmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Joydeep BhattacharyyaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more

    Verified email available

  • Laura ChauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Tim ShannonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 83 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Hootan RashidifardVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Nandu Anilal

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Ran Nussbaum

    Venture Capital, Founder, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Rayfe Gaspar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • ohad hammer

    Venture Capital, Scout, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Byron Ling

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

Frequently asked questions

How many Stargazer Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 17 Stargazer Pharmaceuticals investors. 9 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (13) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Stargazer Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (14), Series A (8) and Seed (1).

Where are Stargazer Pharmaceuticals investors based?

Most are based in the United States (14), Israel (2) and the United Kingdom (1).

Which companies have Stargazer Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Arrakis Therapeutics (15), Bellhops (10), Uniform Teeth (10), Forte (10) and Journey Meditation (10).

How do I contact Stargazer Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.